MedPath

propolis supplementation for the eradication of Helicobacter pylori

Phase 3
Recruiting
Conditions
Patients with Helicobacter pylori infection.
Other diseases of stomach and duodenum
K31.89
Registration Number
IRCT20240622062210N1
Lead Sponsor
Oroumia University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
66
Inclusion Criteria

Patients aged 18-60 years old
Helicobacter pylori infected patients

Exclusion Criteria

Chronic diseases such as diabetes, CKD, Malignancy, gallbladder disorders, peptic ulcer and upper gastrointestinal surgery
Consumption of propolis or other antioxidant supplements or herbal drugs over the past 3 months
allergy to propolis

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath